The Institute of Cancer and Crisis shared a post on LinkedIn:
“90% Of cancer deaths involve drug resistance. New Perspective in BJC Reports
Drug resistance remains oncology’s deadliest challenge. In their latest publication, James Ingham, Jia-Ling Ruan and Matthew Coelho outline an urgent roadmap:
Key Insights from the CRUK/Rosetrees/UKRI Workshop:
- Emerging Hallmarks of Resistance: Beyond genetic mutations – physical forces, microenvironment dynamics
- Lessons from Pandemics: Accelerating data sharing (COVID-19) and cross-therapeutic insights (antimicrobial resistance)
- The Interdisciplinary Imperative: Bridging physics, computation, drug discovery and clinical practice
‘Success requires dismantling silos between physical sciences, biology and clinics.’ ”
Title: Breaking barriers: we need a multidisciplinary approach to tackle cancer drug resistance
Authors: James Ingham, Jia-Ling Ruan, Matthew A. Coelho
Read the Full Article.